Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM180B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | TRMT1L | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CRYBA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RPRM | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZBTB21 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | NDUFAF2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | RAB19 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | SLC6A3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | AC027682.1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | CNPY4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |